HiewonHannMD

PubMed

• Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.
  Man-Fung Yuen, Scott Fung, Xiaoli Ma, Tuan T Nguyen, Tarek Hassanein, Hie-Won Hann, Magdy Elkhashab, Ronald G Nahass, James S Park, Ira M Jacobson, Walid S Ayoub, Stev...> ;JHEP Reports. 2024 Apr 1
• Racial discrimination, knowledge, and health outcomes: The mediating role of hepatitis B-related stigma among patients with chronic hepatitis B.
  Julia G Katcher, Ann C Klassen, Hie-Won Hann, Mimi Chang, Hee-Soon Juon> ;Journal of Viral Hepatitis. 2024 May 1
• Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
  Varghese, N., Majeed, A., Nyalakonda, S., Boortalary, T., Halegoua-DeMarzio, D., Hann, H.> ;Cancers. 2024 Feb 14
• Novel urine cell-free DNA methylation markers for hepatocellular carcinoma.
  Selena Y Lin, Wei Xia, Amy K Kim, Dion Chen, Shelby Schleyer, Lin Choi, Zhili Wang, James P Hamilton, Harry Luu, Hie-Won Hann, Ting-Tsung Chang, Chi-Tan Hu, Abashai Wo...> ;Scientific Reports. 2023 Dec 7
• Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.
  Scott K Fung, Calvin Q Pan, Grace Lai-Hung Wong, Wai-Kay Seto, Sang Hoon Ahn, Chi-Yi Chen, Hie-Won L Hann, Maciej S Jablkowski, Yoon Jun Kim, Cihan Yurdaydin, Cheng-Yu...> ;Alimentary Pharmacology & Therapeutics. 2024 Jan 1
• 3 citations
  Genomic characterization of early-stage hepatocellular carcinoma patients with Hepatitis B using circulating tumor DNA.
  Daniel Lin, Rui Luo, Zhong Ye, Qiang Wei, Ho Bae, Hee-Soon Juon, Hie Won Hann, James Posey, Chun Wang> ;Clinics and Research in Hepatology and Gastroenterology. 2023 Aug 1
• 1 citations
  Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study.
  Selena Y Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su> ;Diagnostics. 2023 Apr 25
• 1 citations
  The Role of Host in the Spectrum of Outcomes in Family Clusters of Hepatitis Infection: From Asymptomatic to Hepatocellular Carcinoma.
  Nicholas Noverati, Anh Nguyen, Divya Chalikonda, Dina Halegoua-DeMarzio, Hie-Won Hann> ;Case Reports in Gastroenterology. 2023 Feb 14
• 17 citations
  Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.
  Mark S Sulkowski, Kosh Agarwal, Xiaoli Ma, Tuan T Nguyen, Eugene R Schiff, Hie-Won L Hann, Douglas T Dieterich, Ronald G Nahass, James S Park, Sing Chan, Steven-Huy B ...> ;Journal of Hepatology. 2022 Nov 1
• 11 citations
  Urine DNA biomarkers for hepatocellular carcinoma screening.
  Amy K Kim, James P Hamilton, Selena Y Lin, Ting-Tsung Chang, Hie-Won Hann, Chi-Tan Hu, Yue Lou, Yih-Jyh Lin, Terence P Gade, Grace Park, Harry Luu, Tai-Jung Lee, Jerem...> ;British Journal of Cancer. 2022 Jun 1
• 5 citations
  First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamide.
  Calvin Q Pan, Nezam H Afdhal, Victor Ankoma-Sey, Ho Bae, Michael P Curry, Douglas Dieterich, Lynn Frazier, Andrew Frick, Hie-Won Hann, W Ray Kim, Paul Kwo, Scott Milli...> ;Hepatology Communications. 2022 Aug 1
• 12 citations
  Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection.
  Man-Fung Yuen, Kosh Agarwal, Xiaoli Ma, Tuan T Nguyen, Eugene R Schiff, Hie-Won L Hann, Douglas T Dieterich, Ronald G Nahass, James S Park, Sing Chan, Steven-Huy B Han...> ;Journal of Hepatology. 2022 Sep 1
• 12 citations
  Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level.
  Madison Force, Grace Park, Divya Chalikonda, Christopher Roth, Micah Cohen, Dina Halegoua-DeMarzio, Hie-Won Hann> ;Viruses. 2022 Apr 8
• 4 citations
  Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress.
  Nicholas Noverati, Rukaiya Bashir-Hamidu, Dina Halegoua-DeMarzio, Hie-Won Hann> ;International Journal of Molecular Sciences. 2022 Apr 1
• 9 citations
  Detection of Hepatitis B Virus-Host Junction Sequences in Urine of Infected Patients.
  Selena Y. Lin, Yih-Ping Su, Evan R. Trauger, Benjamin P. Song, Emilie G.C. Thompson, Malcolm C. Hoffman, Ting-Tsung Chang, Yih Jyh Lin, Yu-Lan Kao, Yixiao Cui, Hie-Won...> ;Hepatology Communications. 2021 Aug 25
• 6 citations
  Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
  Rukaiya Bashir Hamidu, Divya M. Chalikonda, Hie-Won Hann> ;Vaccines. 2021 Jul 30
• 4 citations
  Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes.
  Peter Block, Brianna Shinn, Jin Hyang Kim, Hie-Won L. Hann> ;Hepatic Oncology. 2021 Mar 1
• 50 citations
  Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
  Jin Lin Hou, Wei Zhao, Changhyeong Lee, Hie-Won Hann, Cheng Yuan Peng, Tawesak Tanwandee, Viacheslav Morozov, Hartwig Klinker, Jose D. Sollano, Adrian Streinu-Cercel, ...> ;Clinical Gastroenterology and Hepatology. 2020 Feb 1
• 10 citations
  Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepat...
  Brianna Shinn, Aaron Martin, Robert Coben, Mitchell Conn, Jorge Prieto, Howard Kroop, Anthony J. DiMarino, Hie-Won Hann> ;World Journal of Hepatology. 2019 Jan 27
• 14 citations
  Ferritin level prospectively predicts hepatocarcinogenesis in patients with chronic hepatitis B virus infection
  Zhenyuan Bian, Hie-Won Hann, Zhong Ye, Chun Yin, Yang Wang, Wan Fang, Shaogui Wan, Chun Wang, Kaishan Tao> ;Oncology Letters. 2018 Sep 1
• 20 citations
  Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
  Joseph Yoo, Hie-Won Hann, Robert Coben, Mitchell Conn, Anthony J. DiMarino> ;Diseases. 2018 Apr 20
• 32 citations
  An expert consensus for the management of chronic hepatitis B in Asian Americans.
  Myron J. Tong, Calvin Q. Pan, Steven-Huy B. Han, D. S.-K. Lu, S. Raman, Ke-Qin Hu, Joseph K. Lim, Hie-Won Hann, Albert D. Min> ;Alimentary Pharmacology & Therapeutics. 2018 Feb 26
• 43 citations
  Detection of urine DNA markers for monitoring recurrent hepatocellular carcinoma.
  Hie-Won Hann, Surbhi Jain, Grace Park, Jamin D. Steffen, Wei Song, Ying-Hsiu Su> ;Hepatoma Research. 2017 Jun 6
• 6 citations
  Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients
  Shaogui Wan, Hie-Won Hann, Zhong Ye, Richard S. Hann, Yinzhi Lai, Chun Wang, Ling Li, Ronald E. Myers, Bingshan Li, Jinliang Xing, Hushan Yang> ;Carcinogenesis. 2017 Apr 1
• 10 citations
  Persistent risk for hepatocellular carcinoma after more than a decade of successful hepatitis B virus suppression.
  Andrew Dargan, She Y Wong, Robert Coben, Mitchell Conn, Anthony J. DiMarino, Hie W Hann> ;Minerva Gastroenterologica e Dietologica. 2017 Mar 1
• Join now to see all

Journal Articles

• AST to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic HBV infection  
  Hann HW, Wan S, Lai Y, Hann RS, Myers RE, Patel F, Zhang K, Ye Z, Wang C, Yang H, J Gastroenterol Hepatol, 1/1/2015
• Circulating mitochondrial DNA content associated with the risk of liver cirrhosis: a nested case-control study  
  Wang C, Hann HW, Hann RS, Wan S, Myers RE, Ye Z, Xing J, Yang H, Dig Dis Sci, 1/1/2015
• Giving rituximab in patients with occult or resolved HBV infection: are the current guidelines good enough?  
  Civan J, Hann HW, Exp Opinion Drug Safety, 1/1/2015
• Anti-Viral Therapy Can Prevent Recurrent hepatocellular carcinoma associated with hepatitis B: Recent development  
  Wong SY, Hann HW, J Antivir Antiretrovir, 1/1/2015
• Hepatitis B Virus (HBV) Reactivation Following Immunosuppression in HBsAg (+) carriers  
  Wu R, Hann HW, North Am J Med Sci, 1/1/2015
• Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients with Lamivudine-resistant Chronic Hepatitis B  
  Fung S, Kwan P, Fabri M, Horban A, Pelemis M, Hann HW, Gurel S, Caruntu FA, Flaherty JF, Massetto B, Din P, Corsa A, Subramanian GM, McHutchison JG, Husa p, Gane E, Gastroenterology, 1/1/2014
• Then and Now: The Progress in Hepatitis B Treatment over the Past 20 years  
  Halegoua-DeMarzio D, Hann HW, World J Gastroenterol, 1/1/2014
• Hepatitis C Virus mediated Hepatocellular Carcinoma: a focused review for a time of changing therapeutic options  
  Civan J, Hann HW, NA J Med Sci, 1/1/2014
• A long-term study of the effects of antiviral therapy on survival of patients with HBV associated hepatocellular carcinoma (HCC) following local tumor ablation  
  Hann HW, Coben R, Brown D, Needleman L, Rosato E, Min A, Hann RS, Park KB, Dunn S, DiMarino AJ, Cancer Medicine, 1/1/2014
• Advances in the management of hepatitis B virus infection  
  Hann HW, Gastroenterol & Hepatol, 1/1/2014
• Usefulness of Highly Sensitive AFP-L3 and DCP in Surveillance for Hepatocellular Carcinoma in Patients with a Normal Alpha-Fetoprotein  
  Hann HW, Li D, Yamada H, Satomura S, Coben R, DiMarino AJ, J Med Microb Diagn, 1/1/2014
• Single-center Comparison of Three Chemoembolization Regimens for Hepatocellular Carcinoma  
  Petruzzi NJ, Frangos AJ, Fenkel JM, Herrine SK, Hann HW, Rossi S, Rosato EL, Eschelman DJ, Gonsalves CF, Brown DB, J Vasc Interv Radiol, 1/1/2013
• Development of hepatocellular carcinoma in patients with chronic hepatitis B long after achieving HBsAg seroconversion: A need for an improved hepatitis B virus DNA assay  
  Wong SY, Ren XD, Hann HW, Clinical Microbiology, 1/1/2013
• Hepatitis B: An Overlooked STI, a Silent Threat, a Global Disease  
  Henry CH, Hann HW, Global J Dermatol & Venereol, 1/1/2013
• Hepatitis B-related hepatocellular carcinoma  
  Wong SY, Hann HW, OA Hepatol, 1/1/2013
• Correlates of Hepatitis B Virus Health-Related Behaviors of Korean Americans: A Situation-Specific Nursing Theory  
  Lee H, Fawcett J, Yang JH, Hann HW, J Nurs Scholarsh, 1/11/2012
• Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic...  
  Hann HW, Fu X, Myers RE, Hann RS, Wan S, Kim SH, Au N, Xing J, Yang H, Eur J Cancer, 1/1/2012
• Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection  
  Fu X, Wan S, Hann HW, Myers RE, Hann RS, Au J, Chen B, Xing J, Yang H., Eur J Cancer, 1/1/2012
• Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: a nested case control analysis  
  Wan S, Hann HW, Myers RE, Fu X, Hann RS, Kim SH, Tang H, Xing J,Yang H, Liver Int, 1/1/2012
• Comparison of three chemoembolization regimens for hepatocellular carcinoma: adriamycin and ethiodol has shorter time to progression than cisplatin/adriamycin/mitomyci...  
  Petruzzi NJ, Gupta A, Frangos A, Navarro VJ, Hann HW, Herrine SK, Fenkel JM, Rossi S, Rosato EL, McCann JW, Eschelman DJ, Gonsalves CF, Brown DB, JVIR, 1/1/2012
• Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients  
  Hann HW, Wan S, Myers RE, Hann RS, Xing J, Chen B, Yang H, PLoS One, 1/1/2012
• Prevention of new hepatocellular Carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated  
  Hann HW, Bergin D, Coben R, DiMarino AJ, In J Cancer, 1/1/2011
• Recognition and management of HBV infection in a social context  
  Lee H, Hann HW, Yang JY, Fawcett J, J Cancer Education, 1/1/2011
• Question of ALT flare during switch to Adefovir from Lamivudine: A single center open-label, randomized, safety study  
  Hann HW, Dunn SR, Ahn M, Park SY, J Med Virol, 1/1/2010
• Telbivudine for the treatment of hepatitis B  
  Hann HW, Expert Opinion on Pharmacotherapy, 1/1/2010
• Join now to see all

Books/Book Chapters

• Anyone Can Enjoy Opera, #3 Expanded Edition 
  Hann, HWYeoback, Seoul, Korea2014
• Anyone Can Enjoy Opera, #2 Expanded Edition 
  Hann, HWKwang-Ahm, Seoul, Korea2010
• Hepatocellular Carcinoma: Diagnosis and Treatment 
  Chapter: Hepatocellular Carcinoma Associated with Hepatitis B Virus. 
  Page 235 - 257Hann, HWL, Feitelson, MEditors: Carr, BI.Humana PressEdition 2nd,2010
• Anyone Can Enjoy Opera 
  Hann, HWLife and Dream, Seoul, Korea2002
• Neuroblastoma 
  Chapter: Serum markers and prognosis in neuroblastoma: ferritin, LDH and NSE. 
  Page 371 - 381Hann, HWL, Bombardieri, EEditors: Brodeur, Sawada, Tsuchida and Voute.Elsevier Sciences, B.V.2000
• Confronting Critical Health Issues of Asian and Pacific Islander Americans 
  Chapter: Hepatitis B. 
  Page 149 - 173Hann, HWLEditors: Zane, Takeuchi & Young.Sage Publications1994
• Pediatric Oncology Handbook 
  Chapter: Tumor markers. 
  Page 16 - 22Finlay J and Hann HWLEditors: G.J. D'Angio and D. Sinniah.Edward Arnold (Publisher), London1992
• Iron in Immunity, Cancer and Inflammation 
  Chapter: Iron-related markers in liver cancer. 
  Page 301 - 316Israel JL, McGlynn KA, Hann, HWL, Blumberg BSEditors: M. DeSousa and J. Brock.John Wiley & Sons, Sussex, England1989
• Proc THE NEXT DECADE, 1986 Conf on Refugee Health Care Issues and Management 
  Chapter: Prevention of hepatitis B and primary liver cancer in Asian populations in the US. 
  Page 95 - 109Hann, HWL.,London, W.T., McGlynn, K. and Blumberg, B.S.Editors: T. Phan and M., Katcher.1987
• Advances in Cancer Control: Health Care Financing and Research 
  Chapter: Prevention of primary hepatocellular carcinoma in Asian populations in the Delaware Valley. 
  Page 237 - 246McGlynn, K., London, W.T., Hann, HWL. and Sharrar, R.G.Editors: L.E. Mortenson, P.F. Engstrom and P.N. Anderson.Alan R. Liss, Inc., NY1986
• Third Conference on Advances in Neuroblastoma Research 
  Chapter: Serum ferritin as a prognostic indicator in neuroblastoma: Biological effects of isoferritins. 
  Page 331 - 345Hann, HWL., Stahlhut, M.W. and Evans, A.E.Editors: A.E. Evans, G.J. D'Angio and R.C. Seeger.Alan R. Liss, NY1985
• Ferritins and Isoferritins as Biochemical Markers 
  Chapter: Isoferritins and prognosis oneuroblastoma: The immunological role of acidic isoferritins. 
  Page 171 - 180Hann, HWL., Stahlhut, M.W. and Evans, A.E.Editors: A. Albertini, et al.Elsevier Science Publishers B.V., Amsterdam1984
• Advances in Neuroblastoma Research 
  Chapter: Ferritin and cancer: Study of isoferritins in patients with neuroblastoma. 
  Page 43 - 48Hann, HWL., Levy, H.M. and Evans, A.E.Editors: Evans, A.E..Raven Press1980
• Join now to see all

Abstracts/Posters

• Development of a noninvasive and sensitive urine screening test for liver cancer targeting circulation-derived cancer DNA biomarkers.
  Jain S, Chen S, Lin SY, Clemens A, Hann HW, Chang T-T, Hu C-Tm Chen S-H, Wong W, Su Y-H, AACR, 1/1/2015
• The Doylestown algorithm- a test to improe the performance of AFP in the detection of early stage hepatocellular carcinoma.
  Metha A, Wang M, Davarajan K, Singal AG, Marrero JA, Feng A, Rinaudo JA, Srivastava S, Evans A, Hann HW, Yang H, Javaid A, Poongkuran M, Lau D, Block T, AASLD, 1/1/2015
• Detection of genetic and epigenetic DNA markers in urine for the early detection of primary and recurrent hepatocellular carcinoma.
  Hann HW, Jain S, Lin S, Yi S, Chang T-S, Hu C-T, Song W, Su Y-H, AASLD, 1/1/2015
• Long term efficacy and safety of Tenofovir DF (TDF) in Chornic Hepatitis B Patients (CHB) with Documented Lamivudine Resistance (LAM-R): 5 Year Results From a Randomiz...
  Fung S, Han HW, Elkhashab M, Berg T, Fabri MJ, Horban A, Plemis M, Sporea J, Flaherty JF, Massetto B, Kim K, Kitrinos KM, Subramanian M, Yurdaydin C, Gane E, AASLD, 1/1/2015
• Potential usefulness of highly sensitive AFP-L3% and DCP in risk assessment in surveillance of patient at risk for hepatocellular carcinoma (HCC) with total AFP in ref...
  Hann HW, Li D, Yamada H, Satomura S, DiMarino AJ, DDW, 1/1/2013
• Tenofovir Disoproxil Fumarate (TDF) Is Safe and Well Tolerated in Chronic Hepatitis B (CHB) Patients With Pre-Existing Mild Renal Impairment.
  Scott Fung, Peter Kwan, Andrzej Horban, Mijomir Pelemis, Petr Husa, Hie-Won Hann, John F. Flaherty, Benedetta Massetto, Phillip Dinh, Joseph M. Custodio, G. Mani Subra..., EASL, 1/1/2013
• Comparison of three chemoembolization regimens for hepatocellular carcinoma: adriamycin and ethiodol has shorter time to progression than cisplatin/adriamycin/mitomyci...
  Petruzzi NJ, Gupta A, Frangos A, Navarro VJ, Hann H, Herrine SK, Fenkel JM, Rossi S, Rosato EL, McCann JW, Eschelman DJ, Gonsalves CF, Brown DB, JVIR, SIR 37th Annual Meeting, San Francisco, CA, 1/25/2012
• Half Dose Pegylated Interferon Alpha 2a Therapy Effective for Achieving SVR in Genotype 2/3 Korean Patients with Normal Body Mass Index in a 9 year Study.
  Dadabhai AS, Kim SH, Hann HW, DDW, 1/1/2012
• Association between Telomere Length and Risk of Cirrhosis in Patients with Chronic Hepatitis B.
  Au JS, Hann HW, WanS, Myers RE, Fu X, Navarro VJ, Kim SH, Yang H, DDW, 1/1/2012
• Efficacy and safety of Tenofovir DF(TDF) in chronic hepatitis B virus infected patients with documented lamivudine-resistance (LAM-R).
  Fung S, Kwan WCP, Fabri M, Horban A, Pelemis M, Husa P, Hann HW, Flaherty JF, Massetto B, Dinh P, Kitrinos K, McHutchison JG, Gane E, AASLD, 1/1/2012
• Concomitant antiviral therapy can reduce or prevent recurrent hepatocellular carcinoma (HCC) in patients with chronic hepatitis B.
  Hann HWL, Bergin D, Coben RM, DiMarino AJ, International Symposium for Viral Hepatitis and Liver Disease, 1/1/2009
• A single center, open-label, randomized study comparing the safety of direct switching from lamivudine (LAM) to adefovir dipivoxil (ADV) versus overlapping LAM and ADV...
  Hann HW, DunnSR, Ahn M, Park S, International Symposium for Viral Hepatitis and Liver Disease, 1/1/2009
• Entecavir (ETV) Results in Higher HBV-DNA Reduction vs Adefovir (ADV) in Antiviral-Naive HBeAg(+) Adults with High HBV DNA: 96 Week Results (E.A.R.L.Y. Study).
  Leung N, Peng C-Y, Sollano J,  Lesmana L, Yuen M-F, Jeffers L, Hann HW, Sherman M, Diva U, Mencarini K, Cross A, Wilber R, Lopez-Talavera JC, J of Hepatology (EASL Meeting Abstract), 1/1/2008
• Entecavir (ETV) Therapy in Chronic Hepatitis B Patients Previously Treated with Adefovir (ADV) with Incomplete Response On-treatment or Relapse Off-treatment.
  Lai CL, Elion R, Sherman M, Hann HW, Tyrell DLJ, Liaw YF, Tan CK, Peng CY, Leung N, Mencarini Kim, Zang H, Iloeje U, Kreter B, AASLD Meeting Abstract, 1/1/2008
• Entecavir (ETV) results in higher HBV DNA reduction vs Adefovir (ADV) in chronically infected HBeAg (+) antiviral-naive adults: 48 week results (E.A.R.L.Y.Study).
  Leung, N, Sherman M, Peng C-Y, Sollano J, Lesmana L, Yuen, M-F, Jeffers L, Hann HW, Mencarini K, Colonno R, Cross A, Wilber R, Lopes-Talavera JC for the Entecavi Viral..., J of Hepatology, 1/1/2007
• Tenofovir(TNV) has stronger antiviral effect than adefovir dipivoxil (ADV) against lamivudine (LAM) resistant hepatitis B virus (HBV).
  Hann HW, Chae HB, Dunn S, J of Hepatol, 1/1/2006
• Baseline HBV DNA level is the most important factor associated with viral breakthrough (BT) during lamivudine (LAM) therapy for chronic hepatitis B (CHB).
  Chae HB, Hann HW, Gastroenterology, 1/1/2006
• Tenofovir(TNV) has stronger antiviral effect than adefovir dipivoxil (ADV) against lamivudine (LAM) resistant hepatitis B virus (HBV).
  Hann HW, Chae HB. Dunn S, Gastroenterology, 1/1/2006
• Phase IIb extended-treatment trial of telbivudine (LdT) vs. lamivudine vs. combination treatment in hepatitis B patients: two-year results.
  Lai CL, Leung N, Teo EK, Tong M, Wong F, Hann HW, Han S, Poynard T, Myers M Chao G, Qiao XJ, Lloyd D, Brown N, Gastroenterology, AASLD, 1/1/2005
• Symptomatology and personal attitudes of chronic hepatitis B patients in the United States based on ethnicity and treatment status.
  Hann HW, Block T, Han S, Atillasoy E, Bergstein G, Varshneya R, Gastroenterology, AASLD, 1/1/2005
• Reappearance of wild-type hepatitis B virus during adefovir Reappearance of wild-type hepatitis B virus during adefovir
  Hann HW, Platt JL, Hepatology, 1/1/2005
• Continued clinical improvement following extended treatment with adefovir dipivoxil (ADV) added to ongoing lamivudine (LAM) therapy in chronic hepatitis B (CHB) patien...
  Mutimer D, Schiff E, Buti M, Strasser S, Hann HWL, Woessner M, Brosgart CL, Campbell FM, Scott S, Gardner S, Perrillo R, J. Hepatol, 1/1/2004
• Continued safety and efficacy of adding adefovir dipivoxil (ADV) to ongoing lamivudine (LAM) therapy in compensated chronic hepatitis B (CHB)bpatients with YMDD varian...
  Perrillo R, Willems B, Leung N, Trepo C, Hann HWL, Lau G, Lee WM, Schiff E, Wright T, Scott S, Woessner M, Brosgart CL, Gardner S, J. Hepatol, 1/1/2004
• Results of a One-year International Phase IIB Trial of LdT, and LdT plus lamivudine, in patients with chronic hepatitis B.
  Han S, Leung NWY, Teo E-K, Tong M, Wong F, Hann HW, Poynard T, Myers M, Chao G, Lloyd D, Brown N, Lai C-L, J Hepatol, 1/1/2004
• Improving antiviral therapy in chronic hepatitis B: maximal viral suppression at week 24 correlated with better efficacy at one year.
  Poynard T, Lai CL, Leung NWY, Teo EK, Tong M, Wong F, Hann HW, Han S, Myers M, Chao G, Lloyd D, Brown N, J Hepatol, 1/1/2004
• Join now to see all

Lectures

• "Early Biomarkers for Hepatocellular Carcinoma" 
  Thomas Jefferson University Hospital, Philadelphia, PA - 1/26/2015
• "Hepatitis B and Hepatocellular Carcinoma" 
  Philadelphia, PA - 1/19/2015
• "HBV and hepatocellular carcinoma" 
  Philadelphia, PA - 1/14/2015
• "Artistry of Maria Callas" 
  1/6/2015
• "Treatment of hepatitis B: Is cure possible?" 
  Teaneck, NY - 1/6/2015
• "Persistent Risk for HCC in patients with Chronic Hepatitis B: Is Cure Attainable?" 
  Baruch S. Blumberg Institute, Doylestown, PA - 1/1/2015
• "Global Burden of Hepatitis B" 
  University of Pittsburgh, Pittsburgh, PA - 1/30/2014
• "Hepatitis B: Natural History, Epidemiology and Hepatocellular Carcinoma" 
  Jefferson Medical College, Philadelphia, PA - 1/28/2014
• "Hepatitis B in urban immigrant population" 
  University of Pennsylvania School of Medicine, Philadelphia, PA - 1/25/2013
• "Role of antiviral treatment in Hepatitis B virus associated Hepatocellular Carcinoma." 
  City of Industry, CA - 1/16/2013
• "Opera, Tosca with Callas and Gobbi" 
  1/15/2013
• "Management of chronic hepatitis B in Asian Americans" 
  Los Angeles, CA - 1/15/2013
• "Hepatitis B and Liver Cancer" 
  Jefferson Medical College, Philadelphia, PA - 1/15/2013
• "Update on Tenofovir for the Treatment of Chronic Hepatitis B" 
  Multiple locations - 1/6/2013
• "Hepatitis B treatment in real life-Common and uncommon patient population profiles" 
  Harvard Medical School, Boston, MA - 1/2/2013
• "Management of hepatitis B" 
  Philadelphia, PA - 1/30/2012
• "Update recommendations of HBV treatment in Asian Americans" 
  Philadelphia, PA - 1/23/2012
• "Guidelines for the Management of Hepatitis B in 2012" 
  Atlantic City, NJ - 1/23/2012
• "Introduction to the opera and the artistry of Maria Callas" 
  Orlando, FL - 1/22/2012
• "Role of antiviral therapy for patients with hepatitis B related hepatocellular carcinoma" 
  Orlando, FL - 1/22/2012
• "Management of chronic hepatitis B among Asian Americans" 
  University of California at Irvine, Indian Valley, CA - 1/15/2012
• "The silent crisis: Under diagnosis of Hepatitis B and Liver cancer in the API community" 
  Philadelphia, PA - 1/14/2012
• "Role of antiviral therapy for HBV-associated Hepatocellular Carcinoma" 
  Los Angeles, CA - 1/14/2012
• "Asian American Guideline for the treatment of chronic hepatitis B" 
  Los Angeles, CA - 1/13/2012
• "Concomitant antiviral therapy in patients with HBV-associated Hepatocellular carcinoma." 
  Dong-A Pharmaceutical Research Institute, Seoul, Korea - 1/12/2012
• Join now to see all

Other

• "Anna Bolena, Opera by Donizetti" 
  Hann, HW, Philadelphia Women, 21st issue, pp. 43-50
  1/1/2014
• "Advance in the Treatment of Hepatitis B and Liver Cancer" 
  Hann, HW, Philadelphia Women, 21st issue, pp. 54-58
  1/1/2014
• "Women MDs and Asian American Physicians: are they no longer the minority?" 
  Hann, HW, Philadelphia Women, the 20th issue, pp. 68-71
  1/1/2011
• "Mad Scenes from Il Pirata and Anna Bolena" 
  Hann, HW, Philadelphia Women, the 20th issue, pp. 44-47
  1/1/2011
• Opera ‘L'Elisir d'Amore' 
  Hann, HW, Philadelphia Women, the 19th issue, pp. 27-33
  1/1/2009
• My mother, Lee Kyung Pae. 
  Hann, HW, Philadelphia Women, the 19th issue, pp. 81-87
  1/1/2009
• Opera ‘Turandot' 
  Hann, HW, Philadelphia Women, the 18th issue, pp. 44-48
  1/1/2008
• New therapies for chronic hepatitis B and liver cancer. 
  Hann, HW, Philadelphia Women, the 18th issue, pp. 122-132
  1/1/2008
• HBV Screening and counseling strategies for general practitioners. 
  Hann HWL, Johns Hopkins Advanced Studies in Medicine
  1/1/2007
• If I were to be born again. 
  Hann, HW, Philadelphia Women, the 17th issue, pp. 84-88
  1/1/2006
• Maupassant and Boule de Suif (Tallow Ball). 
  Hann, HW, Philadelphia Women, the 17th issue, pp. 222-227
  1/1/2006
• Opera: "Cavalleria Rusticana" 
  Hann, HW, Philadelphia Women, the 16th issue, pp. 145-148
  1/1/2005
• Recent treatment of hepatitis B and live cancer. 
  Hann, HW, Philadelphia Women, the 16th issue, pp. 150-154
  1/1/2005
• "New Antiviral Agents for Hepatitis B" 
  Hie-Won Yvonne L. Hann, MD, Interview with Philadelphia Weekly (Korean)
  Philadelphia, PA - 1/24/2002
• In memory of my father, Mr. In Soo Lee. 
  Hann, HW, Philadelphia Women, No. 14, pp. 67-75
  1/1/2002
• Opera Nabucco. 
  Hann, HW, Philadelphia Women, No. 14. Pp 84-89
  1/1/2002
• "Two wars against Hepatitis B" (Special one hour series on new trends in treatment in hepatitis B and liver cancer) 
  Hie-Won Yvonne L. Hann, MD, Korean TV Broadcast Station (KBS)
  Seoul, Korea - 1/21/2001
• "Chronic hepatitis B and liver cancer" 
  Hie-Won Yvonne L. Hann, MD, WMBC-TV 63 (TV Interview)
  West Caldwell, NJ - 1/21/2001
• "Korean Immigratns in Philadelphia for the past 25 years and What the immigratns could do to become better citizens" 
  Hie-Won Yvonne L. Hann, MD, Interview with Philadelphia Weekly
  1/16/2001
• "New therapies for chronic hepatitis B and liver cancer" 
  Hie-Won Yvonne L. Hann, MD, WMBC-TV 63
  West Caldwell, NJ - 1/6/2001
• Update of hepatitis B. 
  Hann HWL, Chicago Medicine
  1/1/2001
• Second generation Korean Americans (1). 
  Hann, HW, Korean in America No. 180, pp.28-29, 2001, Korean Publishing & News
  Fort Lee, NJ - 1/1/2001
• "Liver Disease and Liver Cancer among Korean Americans" 
  Hie-Won Yvonne L. Hann, MD, RadioSeoul, Simulcast of TV and Radio Broadcasting
  Flushing, NY - 1/29/2000
• "Update on New therapies for chronic hepatitis B and hepatocellular carcinoma" 
  Hie-Won Yvonne L. Hann, MD, RadioKorea (TV and radiobroadcast through East Coast of the US)
  New York, NY - 1/25/2000
• "Hepatitis B and liver cancer" 
  Hie-Won Yvonne L. Hann, MD, Korean Cable TV Channel 35
  New York, NY - 1/24/2000
• Join now to see all